Skip to content
Review Open access

The role of the gut–brain axis in the pathogenesis of depression and anxiety disorders: The significance of microbiota, bacterial metabolites, and vagus nerve signalling — A systematic review

Aug 2026 · Quality in Sport · Vol 65, pp. 73951 · 0 citations

TL;DR

The gut–brain axis is a biologically plausible, therapeutically tractable contributor to mood and anxiety disorders, though heterogeneity and causal uncertainty remain.

Abstract

Introduction and aim: Depression and anxiety disorders are leading causes of disability worldwide, and many patients respond inadequately to conventional treatment. The microbiota–gut–brain axis has emerged as a candidate contributor to their pathogenesis. This review aimed to synthesise mechanistic and clinical evidence linking gut microbiota, bacterial metabolites, and vagal signalling to depression and anxiety. Material and methods: A systematic search of PubMed, Embase, and Scopus (2011–2025) was performed following PRISMA principles, using terms for the gut–brain axis, microbiota, short-chain fatty acids, tryptophan, vagus nerve, depression, and anxiety. Studies were synthesised narratively across three mechanistic pillars. Results: Patients with depression and anxiety show reduced short-chain-fatty-acid-producing taxa and enrichment of pro-inflammatory bacteria. Bacterial metabolites—short-chain fatty acids, tryptophan catabolites, and gamma-aminobutyric acid—modulate neuroinflammation, blood–brain-barrier integrity, and neurotransmission. Several anxiolytic and antidepressant-like microbial effects are abolished by vagotomy, confirming a vagal route. Randomised trials of psychobiotics show small but significant reductions in depressive symptoms. Conclusions: The gut–brain axis is a biologically plausible, therapeutically tractable contributor to mood and anxiety disorders, though heterogeneity and causal uncertainty remain.

Read PDF

Similar papers

Review Open access Aug 2026

Gut Microbiota and Metabolites: Orchestrating Depression Pathogenesis Through the Microbiota–Gut–Brain Axis’s Neural, Immune, and Metabolic Routes

Specific mechanisms by which the gut microbiota affects depression through the aforementioned pathways are reviewed, including regulating the balance of neurotransmitters, mediating neuroinflammatory responses, and adjusting the levels of metabolites such as short-chain fatty acids.

Zhen-Zhen Dong, Wan-Ying Zheng, Shuo-Jie Lv et al. · 0 citations
Review Open access Sep 2026

GUT MICROBIOTA AND THE GUT–BRAIN AXIS IN ANXIETY DISORDERS: CURRENT EVIDENCE AND THERAPEUTIC PERSPECTIVES

Current evidence indicates that gut microorganisms moderate central nervous system functioning through neural, immunological, endocrine, and metabolic pathways, and available evidence indicates that gut microorganisms moderate central nervous system functioning through neural, immunological, endocrine, and metabolic pa...

Monika Sas-Wyżykowska, Anna Wyżykowska, M. Maruszak et al. · 0 citations
Review Open access Sep 2026

THE GUT-BRAIN AXIS: EXPLORING THE IMPACT OF GUT MICROBIOTA ON MENTAL HEALTH

Current knowledge on the mechanisms by which gut microbiota may influence mental health and microbiota-targeted therapeutic approaches are summarized to clarify causal mechanisms, identify effective microbial interventions, and determine their place in mental health prevention and treatment are summarized.

Agnieszka Kafara, Zuzanna Kafara, Julia Koronczok-Matusiak et al. · 0 citations
Review Open access Sep 2026

Modulation of the Gut Microbiota by Prebiotics, Probiotics, and Psychobiotics and Its Impact on the Gut Microbiota–Brain Axis: A Systematic Review

Simple Summary The gut microbiota–brain axis is a highly integrated bidirectional communication network that plays a fundamental role in maintaining central nervous system homeostasis and regulating neurological function, cognition, and behavior. However, uncertainty remains regarding the effectiveness of microbiota-ta...

Santiago Revelo, Miguel Anchundia · 0 citations
Review Open access Sep 2026

Major approaches and results of clinical studies of the connection gut microbiota-brain and the effects of nutrients and microorganisms in patients with schizophrenia: a systematic review and meta-analysis

A meta-analysis of clinical studies on the relationship between the gut microbiota-brain axis in patients with schizophrenia found that SZ is related to the reduction of bacteria-producing anti-inflammatory butyrate, and improvement trends in psychiatric symptoms for schizophrenia were observed in men treated with prob...

I. Zotarelli, Durval Ribas, M. G. Duarte et al. · 0 citations
Review Open access Sep 2026

The Microbiota-Gut-Brain Axis in Disorders of Gut-Brain Interaction: Mechanisms and Emerging Therapeutic Strategies.

The authors analyze GBA dysfunction across major DGBIs subtypes (irritable bowel syndrome, functional dyspepsia, and functional abdominal pain syndrome), highlighting microbiota dysbiosis, barrier dysfunction, and central sensitization.

Cong Yu, Xiu-Juan Wang, Shu-Zhu Chen · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.